Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Yen-Hao Chen"'
Autor:
Yu-Yin Liu, Ming-Yen Tsai, Ting-Ting Liu, Yueh-Wei Liu, Yu-Hung Lin, Cheng-Hsi Yeh, Yu-Cheng Lin, Yen-Hao Chen
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The aim of this study is to investigate the real-world efficacy and safety of nivolumab in combination with chemotherapy for patients with advanced human epidermal growth factor receptor 2 (HER2)-negative gastric cancer (GC). Meth
Externí odkaz:
https://doaj.org/article/d29cb4af24b547ffbafe161769528711
Autor:
Wei Ho, Shau-Hsuan Li, Shih-Ting Liang, Yu Chen, Li-Chun Chen, Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 5762-5773 (2024)
Background: Lymphadenectomy plays a crucial role in the surgical management of early- stage esophageal cancer. However, few studies have examined lymphadenectomy outcomes in advanced stages, particularly in patients who initially underwent concurrent
Externí odkaz:
https://doaj.org/article/e2d379ae11684ef780eb309385b67627
Publikováno v:
Perioperative Medicine, Vol 13, Iss 1, Pp 1-11 (2024)
Abstract Objectives Esophagectomy after chemoradiotherapy is associated with an increased risk of surgical complications. The significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio after chemoradiotherapy in pred
Externí odkaz:
https://doaj.org/article/09ac19fa6ca04db892c12f1f9bc4d3c5
Autor:
Chung-Shih Chen, Sheng-Dean Luo, Yen-Hsiang Chang, Chen Kai Chou, Shun-Yu Chi, Shao-Chun Wu, Yen-Hao Chen, Johnson Chia-Shen Yang, Eng-Yen Huang, Yu-Ming Wang, Wei-Che Lin
Publikováno v:
International Journal of Hyperthermia, Vol 41, Iss 1 (2024)
Purpose The treatment of recurrent thyroid cancer with critical organ invasion is challenging. The combination of radiofrequency ablation (RFA) and external beam radiation therapy (EBRT) has been proposed as an effective option. This study evaluates
Externí odkaz:
https://doaj.org/article/54e4098e9a6644d9b871a03e2a08e16b
Autor:
Ruei-Ti Ke, Yu-Hsin Hsiao, Wei-Chen Tai, Shau-Hsuan Li, Chih-Chien Yao, Kai-Hao Chuang, Hsing-Hua Lai, Yu Chen, Li-Chun Chen, Hung-I Lu, Yen-Hao Chen, Chien-Ming Lo
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Early-stage esophageal cancer is treated using endoscopic submucosal dissection and esophagectomy. Field cancerization in patients with early-stage esophageal cancer affects treatment outcomes and causes synchronous or metachronou
Externí odkaz:
https://doaj.org/article/d1681cef256a43d780c70d794aaddb63
Autor:
Ya‐Wen Hsiao, Fai‐Meng Sou, Jing‐Houng Wang, Yen‐Hao Chen, Ming‐Chao Tsai, Tsung‐Hui Hu, Chao‐Hung Hung, Chien‐Hung Chen, Yuan‐Hung Kuo
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 12, Pp 1233-1242 (2023)
Abstract Lenvatinib has been approved as one of the first‐line treatments for advanced hepatocellular carcinoma (HCC) due to its high treatment efficacy being non‐inferior to sorafenib. Previous studies have shown well‐controlled viremia contri
Externí odkaz:
https://doaj.org/article/b1252245566d40eeb3fd8e2ddd0e4a28
Autor:
Yen-Hao Chen, Ching-Hua Tsai, Yen-Yang Chen, Chih-Chi Wang, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Nivolumab and pembrolizumab have not been directly compared in clinical trials, and the aim of this study is to investigate the efficacy and safety of nivolumab versus pembrolizumab in patients with advanced hepatocellular carcino
Externí odkaz:
https://doaj.org/article/4968e9b4155e4e21abbd173f7d0859eb
Autor:
Yu-Yin Liu, Yueh-Wei Liu, Gong-Kai Huang, Kuo-Chen Hung, Yu-Hung Lin, Cheng-Hsi Yeh, Shih-Min Yin, Ching-Hua Tsai, Yen-Hao Chen
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 85-99 (2022)
Aldo–keto reductase family 1 member B10 (AKR1B10) is associated with several cancers, but the prognostic role in gastric cancer (GC) remains unclear. We enrolled 359 GC patients who underwent a gastrectomy with D2 lymph node dissection. AKR1B10 exp
Externí odkaz:
https://doaj.org/article/078dda26f9dc4245b229e6acbd969d2e
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background The approved dose of nivolumab is 3 mg/kg or a flat dose of 240 mg for indications. There is no dose-response relationship for nivolumab; therefore, a low-dose regimen may be an option to reduce financial toxicity. This study was
Externí odkaz:
https://doaj.org/article/3582882d69f245ae8e833de29eb529ff
Autor:
Chien-Ming Lo, Kai-Hao Chuang, Hsing-Hua Lai, Yu Chen, Li-Chun Chen, Hung-I Lu, Yen-Hao Chen, Shau-Hsuan Li
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Objectives Esophageal squamous cell carcinoma with pulmonary metastasis has a poor prognosis, and the only treatment modality is systemic therapy such as chemotherapy. Previous studies showed that pulmonary metastasectomy may provide benefit
Externí odkaz:
https://doaj.org/article/24e0f738df074a57b5d0e70e2b2e60a7